This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. Each year, STAT chooses a new class of Wunderkinds, showcasing
More than 60 years ago, policymakers in Colorado embraced the idea that early intervention could prevent child abuse and save lives.
When he recently walked into the dental clinic at the Medical University of South Carolina donning a bright-blue pullover with “In Our DNA SC” embroidered
Christopher Boerner, 53, took over as the chief executive officer of Bristol Myers Squibb last November, and immediately made a big move: a series of
Whether human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) could heal luminal ulcers in Crohn’s disease.
Featured content in this Issue: EQUULUS Therapeutics Emerges from Stealth with Non-Hallucinogenic Ibogaine Analog as Lead Candidate Responses to ICER’s Draft Evidence Report on MDMA-Assisted
The effect of lowering prenatal mother depression on gestational duration.
Share this article The Advanced Research Center will consolidate efforts on key life science technologies. Credit: Merck. Merck KGaA (Merck) has announced an investment of
Share this article Rezafungin is a once-weekly echinocandin intended for the treatment of invasive candidiasis in adults. Credit: nuiza11 via Shutterstock. Mundipharma has signed an